OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes
Jenny Aurielle B. Babon, Megan DeNicola, David M. Blodgett, et al.
Nature Medicine (2016) Vol. 22, Iss. 12, pp. 1482-1487
Open Access | Times Cited: 264

Showing 1-25 of 264 citing articles:

Type 1 diabetes
Linda A. DiMeglio, Carmella Evans‐Molina, Richard A. Oram
The Lancet (2018) Vol. 391, Iss. 10138, pp. 2449-2462
Open Access | Times Cited: 1216

Type 1 diabetes mellitus
Anastasia Katsarou, Soffia Guðbjörnsdóttir, Araz Rawshani, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 1150

HLA variation and disease
Calliope A. Dendrou, Jan Petersen, Jamie Rossjohn, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 5, pp. 325-339
Closed Access | Times Cited: 658

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Bart O. Roep, Sofia Thomaidou, René van Tienhoven, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 3, pp. 150-161
Open Access | Times Cited: 424

Vitiligo: Mechanisms of Pathogenesis and Treatment
Michael L. Frisoli, Kingsley I. Essien, John E. Harris
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 621-648
Closed Access | Times Cited: 392

The heterogeneous pathogenesis of type 1 diabetes mellitus
Jorma Ilonen, Johanna Lempainen, Riitta Veijola
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 11, pp. 635-650
Closed Access | Times Cited: 381

Autoreactive T cells in type 1 diabetes
Alberto Pugliese
Journal of Clinical Investigation (2017) Vol. 127, Iss. 8, pp. 2881-2891
Open Access | Times Cited: 306

T cells in patients with narcolepsy target self-antigens of hypocretin neurons
Daniela Latorre, Ulf Kallweit, Eric Armentani, et al.
Nature (2018) Vol. 562, Iss. 7725, pp. 63-68
Closed Access | Times Cited: 299

T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes
Adam L. Burrack, Tijana Martinov, Brian T. Fife
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 266

New Frontiers in the Treatment of Type 1 Diabetes
Jeremy Warshauer, Jeffrey A. Bluestone, Mark S. Anderson
Cell Metabolism (2019) Vol. 31, Iss. 1, pp. 46-61
Open Access | Times Cited: 201

Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors
Sergio Gonzalez-Duque, Marie Eliane Azoury, Máikel L. Colli, et al.
Cell Metabolism (2018) Vol. 28, Iss. 6, pp. 946-960.e6
Open Access | Times Cited: 184

Current and future therapies for type 1 diabetes
Bernt Johan von Scholten, Frederik Flindt Kreiner, Stephen Gough, et al.
Diabetologia (2021) Vol. 64, Iss. 5, pp. 1037-1048
Open Access | Times Cited: 105

Type 1 diabetes
Teresa Quattrin, Lucy D. Mastrandrea, Lucy S. K. Walker
The Lancet (2023) Vol. 401, Iss. 10394, pp. 2149-2162
Closed Access | Times Cited: 103

Heterogeneity and endotypes in type 1 diabetes mellitus
María J. Redondo, Noel G. Morgan
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 9, pp. 542-554
Closed Access | Times Cited: 65

The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas
Mark A. Atkinson, Raghavendra G. Mirmira
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1500-1518
Open Access | Times Cited: 49

The immunology of type 1 diabetes
Kevan C. Herold, Thomas Delong, Ana Luisa Perdigoto, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 6, pp. 435-451
Open Access | Times Cited: 47

Cystic fibrosis–related diabetes is caused by islet loss and inflammation
Nathaniel Hart, Radhika Aramandla, Gregory Poffenberger, et al.
JCI Insight (2018) Vol. 3, Iss. 8
Open Access | Times Cited: 153

The challenge of modulating β-cell autoimmunity in type 1 diabetes
Mark A. Atkinson, Bart O. Roep, Amanda L. Posgai, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 1, pp. 52-64
Open Access | Times Cited: 140

Use of human islets to understand islet biology and diabetes: progress, challenges and suggestions
Nathaniel Hart, Alvin C. Powers
Diabetologia (2018) Vol. 62, Iss. 2, pp. 212-222
Open Access | Times Cited: 133

B cells in type 1 diabetes mellitus and diabetic kidney disease
Mia J. Smith, Kimber M. Simmons, John C. Cambier
Nature Reviews Nephrology (2017) Vol. 13, Iss. 11, pp. 712-720
Open Access | Times Cited: 124

Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response
Matthew Clark, Charles J. Kroger, Roland Tisch
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 122

NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP)
Klaus H. Kaestner, Alvin C. Powers, Ali Naji, et al.
Diabetes (2019) Vol. 68, Iss. 7, pp. 1394-1402
Open Access | Times Cited: 112

The pathogenesis of thyroid autoimmune diseases: New T lymphocytes – Cytokines circuits beyond the Th1−Th2 paradigm
Qian Li, Bin Wang, Kaida Mu, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 3, pp. 2204-2216
Closed Access | Times Cited: 106

Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes
Pavel Zakharov, Hao Hu, Xiaoxiao Wan, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 6
Open Access | Times Cited: 106

Page 1 - Next Page

Scroll to top